BRPI0703175B8 - anti-inflammatory and anti-allergic cyclic peptides - Google Patents
anti-inflammatory and anti-allergic cyclic peptidesInfo
- Publication number
- BRPI0703175B8 BRPI0703175B8 BRPI0703175A BRPI0703175A BRPI0703175B8 BR PI0703175 B8 BRPI0703175 B8 BR PI0703175B8 BR PI0703175 A BRPI0703175 A BR PI0703175A BR PI0703175 A BRPI0703175 A BR PI0703175A BR PI0703175 B8 BRPI0703175 B8 BR PI0703175B8
- Authority
- BR
- Brazil
- Prior art keywords
- allergic
- inflammatory
- cyclic peptides
- chronic
- acute
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
peptídeos cíclicos antiinflamatórios e antialergicos. a presente invenção refere-se a peptídeos cíclicos sintéticos compreendendo uma sequência de 13 l-aminoácidos em sua estrutura primária, que apresentam atividades antiinflamatórias e antialérgicas, úteis para o tratamento de inflamações e/ou alergias, agudas ou crônicas, sendo particularmente úteis para o tratamento da asma alérgica aguda ou crônica. a invenção também descreve uma composição farmacêutica contendo tais peptídeos, uso e método para tratar ou prevenir desordens inflamatórias e/ou alérgicas, agudas e/ou crônicas.anti-inflammatory and anti-allergic cyclic peptides. the present invention relates to synthetic cyclic peptides comprising a sequence of 13 l-amino acids in its primary structure, which have anti-inflammatory and anti-allergic activities, useful for the treatment of inflammation and/or allergies, acute or chronic, being particularly useful for the treatment of acute or chronic allergic asthma. the invention also describes a pharmaceutical composition containing such peptides, use and method for treating or preventing acute and/or chronic inflammatory and/or allergic disorders.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0703175A BRPI0703175B8 (en) | 2007-07-04 | 2007-07-04 | anti-inflammatory and anti-allergic cyclic peptides |
MX2009000800A MX2009000800A (en) | 2006-07-21 | 2007-07-19 | Anti-inflammatory and antiallergic cyclic peptides. |
JP2009521072A JP5635771B2 (en) | 2006-07-21 | 2007-07-19 | Anti-inflammatory and anti-allergic cyclic peptides |
EP07784915A EP2046815B1 (en) | 2006-07-21 | 2007-07-19 | Anti-inflammatory and antiallergic cyclic peptides |
CN2007800318987A CN101511861B (en) | 2006-07-21 | 2007-07-19 | Anti-inflammatory and antiallergic cyclic peptides |
HK10101668.7A HK1135406A1 (en) | 2006-07-21 | 2010-02-12 | Anti-inflammatory and antiallergic cyclic peptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0703175A BRPI0703175B8 (en) | 2007-07-04 | 2007-07-04 | anti-inflammatory and anti-allergic cyclic peptides |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0703175A2 BRPI0703175A2 (en) | 2009-04-14 |
BRPI0703175B1 BRPI0703175B1 (en) | 2019-04-09 |
BRPI0703175B8 true BRPI0703175B8 (en) | 2021-05-25 |
Family
ID=40612293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0703175A BRPI0703175B8 (en) | 2006-07-21 | 2007-07-04 | anti-inflammatory and anti-allergic cyclic peptides |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0703175B8 (en) |
-
2007
- 2007-07-04 BR BRPI0703175A patent/BRPI0703175B8/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BRPI0703175B1 (en) | 2019-04-09 |
BRPI0703175A2 (en) | 2009-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6362020A2 (en) | MUTANTS FGF21 AND USE OF THE SAME | |
EA202091389A1 (en) | PROBIOTIC-BASED COMPOSITION AND ITS APPLICATION | |
BR112012001984B8 (en) | human antibodies with high affinity for human angiopoietin-2, their use and pharmaceutical composition | |
DE60313597D1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS | |
BR112014033102A2 (en) | product for use in the prophylactic or therapeutic treatment of negative emotion or introvert behavior | |
UY38740A (en) | MUTANTS OF FGF21 AND USES OF THE SAME | |
CL2007003054A1 (en) | PEPTIDE OF 3 TO 40 AMINO ACIDS CAPABLE OF REGULATING NEURONAL EXOCITOSIS; PROCEDURE FOR OBTAINING SUCH PEPTIDE; COSMETIC AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH PEPTIDE; USE OF SUCH PEPTIDE TO TREAT CONDITIONS THAT REQUIRE REGULAR | |
CO6341566A2 (en) | MUTANTS FGF21 AND USES OF THE SAME | |
GT201200250A (en) | ARILTRIAZOLONAS LINKED TO BISARILO AND ITS USE | |
BRPI0613358A8 (en) | polyunsaturated fat acids for the treatment of dementia and conditions related to pre-dementia | |
BRPI0918670B8 (en) | antibody | |
WO2008005303A3 (en) | Thiazolopyrimidine modulators of trpv1 | |
BR112014004444A2 (en) | compositions and methods comprising a lipolytic enzyme variant | |
BRPI0512864A (en) | compositions and methods for treating eye conditions and disorders | |
CL2009000905A1 (en) | Edible composition comprising bifidobacterium longum atcc baa-999; and its use to treat or prevent anxiety and / or anxiety-related disorders. | |
AR113422A2 (en) | RECONSTITUTED SURFACTIVE AGENTS HAVING IMPROVED PROPERTIES | |
BR112015009037A2 (en) | pharmaceutical composition for use in the treatment of myocardial infarction and use of a hmgb1 fragment peptide | |
ATE451100T1 (en) | PHARMACEUTICAL WOUND HEALING COMPOSITIONS IN THE FORM OF A CROME BASED ON AMINO ACIDS AND SODIUM HYALURONATE | |
BR112012020953A2 (en) | product, use thereof, method for prevention and / or treatment of corneal fibrosis or corneal opacity and ophthalmic pharmaceutical composition | |
BRPI0817242A2 (en) | 1,1,1-Trifluoro-2-hydroxy-3-phenylpropane derivative, process for their manufacture, pharmaceutical compositions containing them, method for treating and / or preventing diseases that are associated with modulation of glucocorticoids and use of such compounds | |
CL2009000309A1 (en) | Aromatic fluoroglycoside derivatives, pharmaceutical composition containing these compounds, procedure to prepare it and its use in the treatment of type 1 and type 2 diabetes. | |
BRPI0820967A2 (en) | Use of a composition, pharmaceutical composition and method for treating, ameliorating or prophylaxis of the symptoms of an inflammatory disease. | |
BR112013020283A2 (en) | "use of synaptic vesicle protein inhibitor 2a (sv2a), valproate, levetiracetam, brivarecetam and seletracetam in the treatment of cognitive impairment, as well as pharmaceutical composition comprising the same" | |
RS52867B (en) | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis | |
NI200800253A (en) | TETRAHYDRO-PYRIMIDOAZEPINE AS MODULATORS OF TRPV1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/04/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/07/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |